Back to search

Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with advanced non-small-cell lung cancer. The European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

Data up to Jan 2025

Published1998
Citations277
References23

Total Citations Per Year

Abstract

References (23)

Regression Models and Life-Tables

1992 • 27,454 citations

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

1996 • 2,766 citations

Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials

1996 • 2,541 citations

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1975 • 2,224 citations

WHO Handbook for Reporting Results of Cancer Treatment

1982 • 2,214 citations

Carboplatin dosage: prospective evaluation of a simple formula based on renal function.

1989 • 1,831 citations

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience.

1991 • 732 citations

Tables of the number of patients required in clinical trials using the logrank test

1982 • 694 citations

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.

1989 • 467 citations

Multicenter, randomized comparative study of two doses of paclitaxel in patients with metastatic breast cancer.

1996 • 387 citations

Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: a phase II study.

1997 • 317 citations

Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

1995 • 302 citations

Ninety-six-hour paclitaxel infusion after progression during short taxane exposure: a phase II pharmacokinetic and pharmacodynamic study in metastatic breast cancer.

1996 • 150 citations

Paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a phase II trial.

1996 • 131 citations

Dose-finding and sequencing study of paclitaxel and carboplatin in non-small cell lung cancer

1996 • 31 citations

Two schedules of teniposide with or without cisplatin in advanced non-small-cell lung cancer: a randomized study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

1996 • 27 citations

Dose-finding study of paclitaxel (Taxol) plus cisplatin in patients with non-small cell lung cancer

1995 • 20 citations

Phase I study of paclitaxel (Taxol™) and ifosfamide in previously untreated patients with advanced non-small-cell lung cancer

1996 • 17 citations

Ifosfamide plus paclitaxel in advanced non-small-cell lung cancer: A phase I study

1996 • 17 citations

Teniposide in the treatment of non-small cell lung carcinoma

1987 • 12 citations

New drugs for the management of lung cancer.

1996 • 11 citations

The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.

1996 • 11 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
Randomized study of paclitaxel-cisplatin versus cisplatin-teniposide in patients with… (1998) – Journal of Clinical Oncology | Metascience Observatory Explorer